GENB
Generate Biomedicines, Inc.
Generate Biomedicines, Inc. (GENB) has 1 SEC Form 4 filing (1 transaction rows) in the rolling window, disclosed by 1 distinct insider. Most recent filing: Mar 6, 2026.
Insiders have net bought $240K over the trailing 6 months.
- Industry:Biotechnology
- CEO:Michael T. Nally
- Employees:312
- HQ:Somerville, MA, US
- IPO:2026-02-27
Insider Buying
$240K
reported purchases (SEC code P)
Insider Selling
$0
reported sales (SEC code S)
Unique Insiders
1
in the rolling window
| Source | ||||||
|---|---|---|---|---|---|---|
Nally MichaelFirst filing | Chief Executive Officer | Purchase | 20,000 | $240K | Mar 6 | SEC ↗ |
Related companies
Generate Biomedicines, Inc. is in the Healthcare sector.